Sunday, February 24, 2019 1:04:32 PM
LAS VEGAS, Jan. 23, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – MedCareers Group, Inc. (MCGI: OTC pink) is pleased to announce that it is in final discussions with an institutional investor for a multi-million dollar financing that will be significantly less costly for the company. Additionally, the institutional investor could potentially take over part of the existing debt on the books of the company. The company expects to enter into definitive agreements with this investor in the next two weeks.
The company is also planning to undergo a financial restructuring in order to qualify to uplist to the OTCQB exchange, which is a more senior exchange than the one the company is currently listed on now.
“We are very pleased to have attracted an institutional investor as we work to uplist to the OTCQB,” said Timothy Armes, President and CEO of MedCareers, “Attracting lower cost financing will assist in supporting our anticipated growth for this year and moving forward.”
Follow this story to get email or text alerts from NBC2 when there is a future article following this storyline.
Email address
Follow this story
The Company expects to have the financial statements for its wholly owned subsidiary, The 4 Less Corp., ready within the next two weeks. These financial statements will cover the two fiscal years ended January 31, 2017 and January 31, 2018. The financial statements for year ending January 31, 2019 will be available on the company’s audited year end statements to be filed March 31, 2019.
Recent FLES News
- Efforts to Improve Financial Position Help This Firm Find Early Week Success • AllPennyStocks.com • 03/11/2024 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 12:05:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 02:02:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 02:02:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:14:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 02:00:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:15:01 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2023 09:07:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 08:10:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2023 05:25:50 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 09:34:08 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/29/2023 08:03:10 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 09/19/2023 09:20:40 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/14/2023 08:22:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 08:02:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 01:00:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 01:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 01:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/31/2023 01:09:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/24/2023 01:10:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:02:07 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/11/2023 08:00:43 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM